Logo Image

Peter Salgo, MD, Columbia University Irving Medical Center

Columbia University College of Physicians and Surgeons

Articles by Peter Salgo, MD, Columbia University Irving Medical Center

Barriers to Naloxone Prescribing, Dispensing, and Utilization

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Experts address barriers to overcome regarding naloxone prescribing, dispensing, and utilization that they have seen in the community.

Normalizing the Conversation about Naloxone with the Public

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Multidisciplinary expert panel share perspectives on stigmatization and normalization of the conversation about naloxone between clinicians and patients.

Improving the Accessibility of Naloxone and Potential Impact

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Joshua Lynch, DO, EMT-P, FAAEM, FACEP, shares ways to improve naloxone accessibility, and Theresa Mallick-Searle, MS, RN-BC, ANP-BC, discusses stigmatization.

Implementing Protocols, Policies, and Programs to Save Lives

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Experts weigh in on protocols, policies, and programs that influence patient safety and address when a conversation should ensue with patients about naloxone.

Increasing Patient Adherence to Schizophrenia Treatment Regimen

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine

Rahn Bailey, MD, DFAPA, and Henry Nasrallah, MD, explain how to increase patient adherence to treatment and address the stigma associated with schizophrenia even in the family of the patient.

New Labeling Requirements Put Forth by the FDA for Opioids

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Theresa Mallick-Searle, MS, RN-BC, ANP-BC, shares her perspective on the new labeling requirements put forth by the FDA for opioids in regards to naloxone.

Risks for Accidental Opioid Overdose Seen in the Community

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Joshua Lynch, DO, EMT-P, FAAEM, FACEP, highlight risks he has seen in the community for unintended users as well as patients for accidental opioid overdose.

Psychiatric Teams: Treating Schizophrenia Comorbidities

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine

Rahn Bailey, MD, DFAPA, and Henry Nasrallah, MD, discuss the challenges and unmet needs psychiatrists and their teams face when treating patients with schizophrenia and their multiple comorbidities.

Opioid Crisis Misconceptions and Unintended Consequences

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Jeffrey Bratberg, PharmD, FAPhA, leads discussion tackling common opioid-related misconceptions as well as unintended consequences of the opioid crisis.

Current State of the Opioid Crisis: Multifaceted Point of View

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Jeremy Adler, DMSc, PA-C, DFAAPA, leads discussion on elements that negatively impacts the quality of care for patients requiring pain management.

Unmet Needs and the Impact of COVID-19 on the Opioid Crisis

ByPeter Salgo, MD, Columbia University Irving Medical Center ,Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants ,Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy ,Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Stanford Health Care ,Charles Argoff, MD, Albany Medical Center

Experts discuss opioid crisis complexities, such as the able to manage pain appropriately and the impact of social and structural determinates of health.